Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

TELIX PHARMACEUTICALS US INC

UEI: NMRHMBK4YTH7CAGE: 8CP27

TELIX PHARMACEUTICALS US INC is a federal contractor, registered under UEI NMRHMBK4YTH7 and CAGE code 8CP27. It has been awarded $11,197,692 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

NMRHMBK4YTH7

CAGE Code

8CP27

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Telix Pharmaceuticals US Inc. specializes in the manufacturing and supply of radiopharmaceuticals for nuclear medicine applications, with a focused expertise in prostate cancer imaging and targeted radionuclide therapies. The company produces clinically validated agents such as ILLUCCIX and gozetoti...

Telix Pharmaceuticals US Inc. specializes in the manufacturing and supply of radiopharmaceuticals for nuclear medicine applications, with a focused expertise in prostate cancer imaging and targeted radionuclide therapies. The company produces clinically validated agents such as ILLUCCIX and gozetotide, which are used in PSMA-targeted diagnostic imaging to enable precise tumor detection and staging. Their technical capabilities encompass GMP-compliant radiopharmaceutical synthesis, radioisotope handling, cold kit formulation, and just-in-time distribution of short-half-life isotopes to clinical settings. A key differentiator is their ability to deliver complex, time-sensitive radiopharmaceuticals under stringent regulatory standards, ensuring consistent product integrity for use in VA nuclear medicine departments. The Department of Veterans Affairs is the contractor’s primary and consistent federal partner, with recurring contracts for the procurement of PSMA-targeted radiopharmaceuticals and other specialized nuclear imaging agents. These engagements reflect a trusted, ongoing relationship in which Telix serves as a critical supplier for VA medical centers requiring reliable access to advanced diagnostic radiopharmaceuticals for veteran patient care. Operating under NAICS 325412, the company is positioned at the intersection of pharmaceutical manufacturing and diagnostic imaging, serving the growing demand for precision oncology solutions in government healthcare systems. Their market focus is narrowly defined on radiopharmaceuticals for oncologic and neurologic applications, distinguishing them as a niche provider within the broader pharmaceutical manufacturing sector. As a 2L entity headquartered in Fishers, Indiana, Telix Pharmaceuticals US Inc. is a mid-sized manufacturer with no federal certifications on record. The company’s geographic presence is centered in the Midwest, supporting federal healthcare logistics through strategic distribution networks that meet the unique temporal and regulatory demands of radiopharmaceutical delivery.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

24

All time

Active

4

Currently performing

Completed

19

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with TELIX PHARMACEUTICALS US INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for TELIX PHARMACEUTICALS US INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in TELIX PHARMACEUTICALS US INC's top NAICS codes and agencies

NAICS: 325412
New
DIBBS
CHARCOAL, ACTIVATED, SUS
Solicitation # SPE2DP-27-T-0383
Solicitation SPE2DP-27-T-0383 is a small business set-aside procurement for the Department of Defense, specifically the Medical Supply Chain Pharm FSA, for the supply of activated charcoal suspension. The requirement is for four bottles, each containing 50 grams in a 240 ml volume (NSN 6505-01-282-880), with a required delivery date of November 17, 2026. Delivery is specified as FOB Destination to a shipping address in Poland, with a required delivery timeline of 20 days after order. The material must be stored between 20 and 25 degrees Celsius and must have a shelf life of 36 months, with no more than five months elapsed from the date of manufacture to the date of delivery. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Marking must follow Medical Marking Standard No. 1, and labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and receiving reports. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, cybersecurity safeguarding, and hazardous material identification. Inspection and acceptance will be performed at the destination per FAR 52.246-2.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 1 hour ago

DEADLINE

in 7 days
View Details